Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...
Investor's Business Daily on MSN20h
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...
Talat Imran; Chief Executive Officer, Director; Rani Therapeutics Holdings Inc Svai Sanford; Chief Financial Officer; Rani Therapeutics Holdings Inc Welcome to the Rani fourth-quarter and full-year ...
The Spring-into-Summer offerings this year in the classical realm are as rich, diverse, and extensive as ever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback